Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...